Saturday 17 October 2026
Export OPCH’s income statement to Excel — free account
Option Care Health, Inc.
OPCH Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 1.86%, EPS grew 12.9%, free cash flow grew 112.4% and total debt rose 4.38%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
31.20
0.02
−0.06%
Follow OPCH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 36.27 | 35.54 | 23.03 | 18.56 | 24.89 |
Piotroski F-Score |
5 | 6 | 5 | 3 | 6 | 9 | 6 | 9 | 6 | 5 |
P/S ratio |
0.14 | 0.95 | 1.05 | 1.01 | 0.93 | 1.49 | 1.35 | 1.43 | 0.80 | 0.91 |
Altman Z-Score |
0.18 | 3.14 | 3.10 | 1.78 | 2.37 | 3.49 | 3.67 | 4.05 | 3.42 | 3.92 |
P/FCF ratio |
0.00 | 130.28 | 0.00 | 0.00 | 28.16 | 27.96 | 21.64 | 18.43 | 13.83 | 23.78 |
Altman Z″-Score (non-manufacturers) |
(3.06) | (2.77) | 1.95 | 1.03 | 1.36 | 1.86 | 2.46 | 2.92 | 3.04 | 2.97 |
Beneish M-Score |
(2.25) | (3.01) | (0.01) | (2.62) | (2.65) | (2.53) | (2.54) | (2.65) | (2.51) | (2.38) |
P/Operating CF |
(32.55) | 36.91 | 166.52 | 101.83 | 110.29 | 78.32 | 122.95 | 120.48 | 110.19 | 143.89 |
P/B ratio |
0.00 | 0.00 | 3.38 | 2.57 | 2.79 | 4.35 | 3.85 | 4.32 | 2.83 | 3.89 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.61 | 1.19 | 1.31 | 1.54 | 1.27 | 1.76 | 1.55 | 1.59 | 0.94 | 1.08 |
EV/EBITDA |
37.98 | 31.93 | 30.81 | 57.19 | 19.86 | 22.90 | 19.72 | 17.99 | 12.00 | 14.76 |
EV/Operating CF |
(13.46) | 57.61 | 103.96 | 89.98 | 30.26 | 29.06 | 22.85 | 18.47 | 14.47 | 23.57 |
EV/FCF |
(11.87) | 162.83 | (1,374.19) | (913.83) | 38.36 | 33.13 | 24.76 | 20.59 | 16.26 | 28.06 |
Quick Ratio |
0.91 | 1.24 | 1.44 | 1.19 | 0.99 | 1.00 | 1.19 | 1.17 | 1.05 | 0.85 |
Current Ratio |
1.33 | 1.77 | 1.95 | 1.69 | 1.51 | 1.55 | 1.76 | 1.77 | 1.70 | 1.53 |
Net Debt/EBITDA |
29.34 | 6.38 | 6.10 | 19.64 | 5.28 | 3.58 | 2.48 | 1.89 | 1.79 | 2.25 |
Debt/Assets |
74.70% | 79.69% | 37.77% | 49.68% | 42.47% | 38.19% | 34.19% | 33.03% | 32.47% | 33.59% |
Debt/Equity |
11.77 | (5.67) | 0.89 | 1.42 | 1.11 | 0.91 | 0.77 | 0.75 | 0.79 | 0.88 |
Asset Turnover |
1.65 | 3.03 | 1.91 | 1.15 | 1.16 | 1.26 | 1.34 | 1.36 | 1.51 | 1.64 |
Operating CF/Net income |
0.82 | 9.77 | (3.99) | (0.52) | (15.77) | 1.49 | 1.78 | 1.39 | 1.53 | 1.25 |
Capex/Depreciation |
(0.22) | (0.60) | (0.59) | (0.45) | (0.32) | (0.35) | (0.30) | (0.57) | (0.52) | (0.55) |
Interest Coverage |
(0.29) | 0.62 | 0.84 | 0.00 | 1.03 | 2.85 | 4.46 | 6.14 | 6.56 | 6.19 |
| 90.57% | (6.55%) | (2.36%) | (10.06%) | (0.84%) | 12.77% | 11.75% | 19.03% | 14.99% | 15.20% | |
| (9.13%) | 0.64% | (0.60%) | (3.78%) | (0.31%) | 5.14% | 5.10% | 8.44% | 6.38% | 6.04% | |
ROIC |
(1.43%) | 4.85% | 2.16% | (0.01%) | 3.39% | 5.62% | 6.96% | 9.19% | 9.57% | 9.37% |
Return on Tangible Assets |
(68.35%) | 3.58% | (1.91%) | (20.98%) | (2.35%) | 38.64% | 28.02% | 44.77% | 31.62% | 36.11% |
Average Days of Receivables |
42.56 | 17.08 | 58.36 | 51.25 | 39.52 | 35.90 | 34.93 | 32.04 | 29.92 | 30.60 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
4.15% | 18.51% | 17.83% | 19.89% | 16.49% | 15.29% | 14.35% | 14.12% | 12.61% | 12.08% |
Intangible Assets out of Total Assets |
0.66 | 0.64 | 0.60 | 0.70 | 0.55 | 0.54 | 0.50 | 0.49 | 0.46 | 0.47 |
Share Based Compensation of Revenue |
0.19% | 0.08% | 0.11% | 0.18% | 0.10% | 0.28% | 0.43% | 0.71% | 0.72% | 0.71% |
Graham Net Nets |
(3.02) | (0.29) | (0.18) | (0.48) | (0.34) | (0.18) | (0.14) | (0.11) | (0.17) | (0.17) |
Graham Number |
8.43 | 6.29 | 0.00 | 0.00 | 0.00 | 10.74 | 11.96 | 16.32 | 15.17 | 15.35 |
Earnings Yield |
(39.57%) | (24.18%) | (11.12%) | (3.29%) | (0.26%) | 2.76% | 2.81% | 4.34% | 5.39% | 4.02% |
Free Cash Flow Yield |
(37.02%) | 0.77% | (0.09%) | (0.17%) | 3.55% | 3.58% | 4.62% | 5.43% | 7.23% | 4.20% |
Revenue per Share |
39.92 | 12.82 | 13.60 | 14.78 | 16.76 | 19.12 | 21.78 | 24.04 | 29.13 | 34.85 |
Operating CF per Share |
(1.82) | 0.27 | 0.17 | 0.25 | 0.70 | 1.16 | 1.48 | 2.07 | 1.88 | 1.59 |
Capex per Share |
(0.24) | (0.17) | (0.18) | (0.18) | (0.15) | (0.14) | (0.11) | (0.21) | (0.21) | (0.25) |
Free Cash Flow per Share |
(2.06) | 0.09 | (0.01) | 0.07 | 0.56 | 1.02 | 1.36 | 1.86 | 1.68 | 1.34 |
Cash per Share |
0.41 | 0.31 | 0.26 | 0.43 | 0.55 | 0.66 | 1.62 | 1.92 | 2.40 | 1.44 |
Shareholders Equity per Share |
1.64 | (0.59) | 4.23 | 5.80 | 5.61 | 6.54 | 7.65 | 7.94 | 8.18 | 8.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.64 | (0.59) | 4.23 | 5.80 | 5.61 | 6.54 | 7.65 | 7.94 | 8.18 | 8.18 |
Free Cash Flow |
(48.23) | 13.40 | (1.85) | 11.19 | 100.52 | 182.94 | 246.86 | 333.17 | 287.79 | 217.14 |
Working Capital |
43.18 | 81.46 | 227.43 | 228.65 | 222.99 | 250.56 | 428.99 | 475.95 | 542.48 | 435.62 |
Capital Expenditures |
(5.69) | (24.47) | (26.28) | (28.28) | (26.87) | (25.63) | (20.69) | (38.12) | (35.61) | (41.31) |
Net Current Asset Value |
(393.28) | (501.25) | (357.96) | (1,124.07) | (974.70) | (904.78) | (732.49) | (701.11) | (694.88) | (864.41) |
EV/EBIT |
0.00 | 79.98 | 66.36 | 0.00 | 34.81 | 31.76 | 25.44 | 21.80 | 14.54 | 18.03 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
0.00 | 63.99 | 53.22 | 0.00 | 25.56 | 26.80 | 22.24 | 19.52 | 12.37 | 15.28 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.80 | 1.52 | 0.47 | 0.47 | 0.69 | 0.66 | 0.64 | 0.55 | 0.53 | 0.54 |
Cash ROIC |
(9.65%) | 3.04% | (0.16%) | 0.49% | 4.49% | 7.75% | 8.99% | 11.78% | 9.83% | 7.98% |
Accounts Receivable Turnover |
9.06 | 18.79 | 9.80 | 7.28 | 9.29 | 10.32 | 11.02 | 11.39 | 12.70 | 12.79 |
Accounts Payable Turnover |
10.40 | 21.20 | 11.96 | 8.79 | 9.33 | 9.46 | 9.35 | 8.25 | 7.68 | 7.30 |
Inventory Turnover |
17.02 | 37.25 | 25.00 | 18.04 | 17.13 | 15.56 | 15.11 | 13.33 | 12.04 | 10.62 |
Average Days of Payables |
34.91 | 17.42 | 45.19 | 44.89 | 43.94 | 38.33 | 44.92 | 46.88 | 55.94 | 51.20 |
Days of Inventory on Hand |
19.60 | 10.05 | 20.04 | 23.53 | 24.63 | 25.13 | 26.60 | 30.11 | 35.55 | 37.70 |
Average Receivables |
103.22 | 97.30 | 197.85 | 317.29 | 326.38 | 333.29 | 357.89 | 377.60 | 393.70 | 441.65 |
Average Payables |
64.75 | 65.19 | 126.92 | 204.47 | 251.99 | 281.08 | 329.00 | 402.64 | 518.65 | 625.30 |
Average Inventory |
39.57 | 37.10 | 60.69 | 99.61 | 137.24 | 170.85 | 203.69 | 249.14 | 331.07 | 429.64 |
Average Assets |
567.81 | 604.04 | 1,015.65 | 2,008.88 | 2,618.49 | 2,719.18 | 2,951.93 | 3,164.99 | 3,319.39 | 3,438.76 |
Average Common Equity |
(57.25) | (59.19) | 259.04 | 754.83 | 961.28 | 1,095.81 | 1,280.99 | 1,403.89 | 1,412.96 | 1,365.32 |
Columns are period end dates